PLoS ONE · 2014 · 39 citations · 22 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntiparasitic PharmacologyStructure-activity Relationship AnalysisAntileishmanial TreatmentAntimalarial ChemotherapyAntimalarial Drug DevelopmentAntiparasitic Drug DesignChemical Structure-activity RelationshipsLeishmania Life CycleLeishmaniasis PathogenesisTreatment Of Leishmaniasis
Naphtoquinones have been used as promising scaffolds for drug design studies against protozoan parasites. Considering the highly toxic and limited therapeutic arsenal, the global negligence with tropical diseases and the elevated prevalence of co-morbidities especially in developing countries, the parasitic diseases caused by various Leishmania species (leishmaniasis) became a significant public health threat in 98 countries. The aim of this work was the evaluation of antileishmanial in vitro potential of thirty-six 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinones obtained by a three component reaction of lawsone, the appropriate aldehyde and thiols adequately substituted, exploiting the in situ generation of o-quinonemethides (o-QM) via the Knoevenagel condensation. The antileishmanial activity of the naphthoquinone derivatives was evaluated against promastigotes and intracellular amastigotes of Leishmania (Leishmania) infantum and their cytotoxicity was verified in mammalian cells. Among the thirty-six compounds, twenty-seven were effective against promastigotes, with IC50 values ranging from 8 to 189 µM; fourteen compounds eliminated the intracellular amastigotes, with IC50 values ranging from 12 to 65 µM. The compounds containing the phenyl groups at R1 and R2 and with the fluorine substituent at the phenyl ring at R2, rendered the most promising activity, demonstrating a selectivity index higher than 15 against amastigotes. A QSAR (quantitative structure activity relationship) analysis yielded insights into general structural requirements for activity of most compounds in the series. Considering the in vitro antileishmanial potential of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinones and their structure-activity relationships, novel lead candidates could be exploited in future drug design studies for leishmaniasis.
22
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar, Iván Darío Vélez, Caryn Bern et al. · PLoS ONE · 2012 · 5.2K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
An improved colorimetric assay for interleukin 2
Hiroko Tada, Osamu Shiho, Ken-ichi Kuroshima et al. · Journal of Immunological Methods · 1986 · 872 citations
Global framework on essential health R&D
Pierre Chirac, Els Torreele · The Lancet · 2006 · 166 citations